Walleye Trading
PCRX icon

Walleye Trading’s Pacira BioSciences PCRX Stock Holding History

Walleye Trading’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-130,400
Closed -$3.73M – 4471
2024
Q2 		$3.73M Buy
130,400
+38,300
+42% +$1.09M 0.01% 1223
2024
Q1 		$2.69M Buy
92,100
+81,000
+730% +$2.49M 0.01% 1548
2023
Q4 		$375K Buy
11,100
+11,000
+11,000% +$322K ﹤0.01% 3318
2023
Q3 		$3.07K Buy
+100
New +$3.6K ﹤0.01% 4703
2023
Q1 		– Sell
-1,700
Closed -$65.6K – 5247
2022
Q4 		$65.6K Sell
1,700
-100
-6% -$4.87K ﹤0.01% 4126
2022
Q3 		$96K Buy
1,800
+1,700
+1,700% +$94.5K ﹤0.01% 4066
2022
Q2 		$6K Sell
100
-3,200
-97% -$210K ﹤0.01% 4753
2022
Q1 		$252K Buy
3,300
+600
+22% +$40K ﹤0.01% 3604
2021
Q4 		$162K Buy
+2,700
New +$149K ﹤0.01% 4063
2021
Q3 		– Sell
-6,600
Closed -$400K – 5582
2021
Q2 		$400K Buy
+6,600
New +$418K ﹤0.01% 3175
2020
Q1 		– Sell
-5,400
Closed -$245K – 4410
2019
Q4 		$245K Buy
+5,400
New +$229K ﹤0.01% 3002
2019
Q3 		– Sell
-5,300
Closed -$230K – 4333
2019
Q2 		$230K Buy
+5,300
New +$225K ﹤0.01% 2832
2019
Q1 		– Sell
-900
Closed -$39K – 4633
2018
Q4 		$39K Sell
900
-42,900
-98% -$2M ﹤0.01% 4213
2018
Q3 		$2.15M Buy
+43,800
New +$1.89M 0.01% 1253
2017
Q2 		– Sell
-2,700
Closed -$123 – 4834
2017
Q1 		$123 Buy
2,700
+1,800
+200% +$77.8K ﹤0.01% 3284
2016
Q4 		$29K Buy
+900
New +$30K ﹤0.01% 3932

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Walleye Trading's PCRX Position: Q3 2024 in Review

Walleye Trading sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 35,873 shares — an estimated $1.03M sold.

Walleye Trading first reported a position in PCRX in Q4 2015 and held it in 14 quarters. The position peaked at $1.03M in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Walleye Trading reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Walleye Trading sold 35,873 Pacira BioSciences shares in Q3 2024, an estimated $1.03M.
  • Walleye Trading first reported a position in Pacira BioSciences in Q4 2015 and held it in 14 quarters.
  • Walleye Trading's Pacira BioSciences position peaked at $1.03M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.